跳至主要内容
临床试验/KCT0007132
KCT0007132已完成未知

Effects of Anesthetic agents (propofol vs. remimazolam) on recovery outcomes in patients undergoing arrhythmia catheter ablation: a prospective, randomized, and controlled trial

Samsung Medical Center0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 70(Year)(—)
性别
All

入选标准

  • 1) ASA class I-IV adult (19-70 years of age)
  • 2) Undergoing elective cathter ablation procedure for atrial fibrillation/flutter under general anesthesia

排除标准

  • 1) History of hypersensitivity to benzodiazepines or propofol
  • 2) Moderate liver disease (Child-Pugh B/C)
  • 3) Diagnosed with metabolic disease
  • 4) Pregnant or breast-feeding
  • 5) Acute glaucoma
  • 6) Galactose intolerance, lactose intolerance, or glucose-galactose absorption disorder
  • 7) Severe hypersensitivity to Dextran 40

研究者

相似试验